The Man Van Project

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4000 participants.

Also called NCT06357416

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 4,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06357416
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06357416. Non-randomized; no masking; primary purpose diagnostic. Start 2022-04-13 (actual); primary completion 2025-10-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Man Van Project
Acronym
MV
Condition
Prostate Cancer
Condition
Urologic Cancer
Condition
Urologic Diseases
Condition
Bladder Cancer
Condition
Diabetes
Condition
Hypertension
Condition
Mental Health Issue
Condition
Alcoholism
Condition
Smoking
Condition
Renal Cancer
Condition
Testis Cancer
Intervention (Device)
MV-POCT Sub-study
Intervention (Other)
Main Man Van Group Sub-study (MV-Eco)
Intervention (Other)
MV-QualQ Sub-study
Intervention (Diagnostic test)
MV-PRS Sub-study
Intervention (Other)
MV-DNA and MV-UctDNA Sub-study
Intervention (Other)
Man Van patients
Intervention (Other)
MV-SSI Sub-study
Intervention (Other)
MV-TPP Sub-study
Lead sponsor
Royal Marsden NHS Foundation Trust (class: other)
Collaborator
RM Partners West London Cancer Alliance (class: not stated)
Collaborator
Institute of Cancer Research, United Kingdom (class: other)
Collaborator
Imperial College London (class: other)

Record details

Record id
cardio:ct-nct06357416
Content hash
c66d42aaef7d7cf44d94daab42dbb36e2933b7ccbe590497ebf93a6e6230c57c